[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649552":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":24,"locations":34,"responsibleParty":52,"collaborators":10,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":67,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"The University of Texas Health Science Center, Houston","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Adult patients who undergo EUS-RFA for treatment of pancreatic lesions",null,[12],"Device: Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DEVICE","Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)","EUS-guided Radiofrequency Ablation (RFA) consists of the application of alternating current with a frequency of 350-500 kHz (coincidentally the frequency range of radio broadcasts as well) to the target tissue via a special electrode located at the tip of the endoscope.",[9],[20],{"name":21,"affiliation":22,"role":23},"Nirav Thosani, MD","The University of Texas Health Science Center at Houston (UTHealth Houston)","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Amatullah Alibhai, MBA","CONTACT","713-500-6658","Amatullah.Alibhai@uth.tmc.edu",{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},"Nicole Fatheree, BBA","713-500-5669","Nicole.Fatheree@uth.tmc.edu",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"The University of Texas Health Science Center at Houston","RECRUITING","Houston","Texas","77030","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-95.36327,29.76328,{"lat":47,"lon":46},[50,51],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},{"type":23,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Nirav C Thosani","Professor","100649552","safety-and-efficacy-of-endoscopic-ultrasound-eus-guided-radiofrequency-ablation-rfa-in-the-treatment-of-pancreatic-lesions-100649552",false,"NCT07737171","Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions","Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions: A Pancardinal-4 Prospective Registry","Inclusion Criteria:\n\n* Diagnosis of any pancreatic pre-malignant lesion and\u002For pancreatic malignancy\n* Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically\n\nExclusion Criteria:\n\n* Patients with co-existing malignancies of other organs (or a prior history of such)\n* Patients unable to provide informed consent\n* Patients unable to complete follow-up","ALL","18 Years",{"count":65,"type":66},60,"ESTIMATED","3 Years","OBSERVATIONAL","This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.",[71],"Pancreatic Cancer","2026-07-27",{"date":74,"type":75},"2026-07-30","ACTUAL",{"date":77,"type":75},"2026-04-07",{"date":79,"type":66},"2033-04-01",{"name":5,"class":6},1]